XORTX THERAPEUTICS
XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy and polycystic kidney disease with secondary programs focused on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease. At XORTX Therapeutics, they are dedicated to developing medications to improve the quality of life and future health of patients.
XORTX THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Address:
Calgary, Alberta, Canada
Country:
Canada
Website Url:
http://www.xortx.com
Total Employee:
1+
Status:
Active
Contact:
+1 747 203 5240
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Apache Euro Microsoft Exchange Online
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-02 | XORTX Therapeutics Appoints Altasciences as CRO for Clinical Study |
Official Site Inspections
http://www.xortx.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Xortx Therapeutics"
Xortx Therapeutics - Crunchbase Company Profile & Funding
XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop …See details»
About :: XORTX Therapeutics Inc. (XRTX)
XORTX Therapeutics, Inc. is a drug based biotechnology company primarily focused on orphan disease indications which have aberrant purine metabolism and frequently high serum uric acid imbalance. Our focus on developing …See details»
Xortx Therapeutics Inc (XRTX-X) Profile - The Globe and Mail
Nov 24, 2022 See the company profile for Xortx Therapeutics Inc (XRTX-X) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
XORTX Provides Corporate Update :: XORTX Therapeutics Inc. (XRTX)
Jan 31, 2022 XORTX common shares commenced trading on the TSX Venture Exchange under the symbol XRTX and its common shares ceased trading on the Canadian Securities …See details»
XORTX Therapeutics Inc. - Canadian Securities Exchange
Sep 30, 2015 XORTX Therapeutics Inc. is a pharmaceutical company with two clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney …See details»
XORTX Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XORTX Therapeutics Inc of Calgary, AB. Get the latest business insights from Dun & Bradstreet.See details»
XORTX Therapeutics Company Description - Stock Analysis
Oct 24, 2024 XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, …See details»
XORTX Company Profile - Office Locations, Competitors, Revenue …
Nov 10, 2021 XORTX. Stock Price. $3.9. 2021-11-10. Market Capitalization. $528.4 M. 2021-11-10. XORTX Summary. Company Summary. Overview. XORTX Therapeutics is a drug …See details»
XORTX Therapeutics - Overview, News & Similar companies
May 17, 2024 XORTX Therapeutics is a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney disea ses, …See details»
Xortx Therapeutics - Contacts, Employees, Board Members
XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney diseaseSee details»
XORTX Clarifies Timing for Share Consolidation - Financial Post
Nov 10, 2023 Article content. CALGARY, Alberta, Nov. 10, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | …See details»
XORTX Provides Corporate Update :: XORTX Therapeutics Inc. (XRTX)
Jan 19, 2021 March 2020 – XORTX filed a provisional patent focused on the treatment and prevention of the health consequences of COVID-19 infection, and specifically AKI. July 2020 - …See details»
XORTX Therapeutics Inc, ANUA:MUN profile - FT.com - Financial …
Nov 28, 2024 XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by …See details»
XORTX Therapeutics Inc. (XRTX) - Yahoo Finance Canada
XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, pre …See details»
XORTX - eResearch
O XORTX has 2 therapies - XRx-008 and XRx-101 close to pivotal Phase 3, registration, clinical trials. o XORTX is fully funded to rapidly advance toward the approval of its first product within …See details»
XRTX Stock Price Quote | Morningstar
Oct 11, 2024 XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney …See details»
XORTX Highlights Pioneering Research Indicating a Role for …
Aug 29, 2024 XORTX is a pharmaceutical company with two clinically advanced products in development: 1) our lead, XRx-008 program for ADPKD; and 2) our secondary program in …See details»
XORTX Provides Corporate Update
Jan 19, 2021 Synopsis of 2020 Achievements and Key Activities for 2021 CALGARY, Alberta, Jan. 19, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the …See details»
XORTX Announces Positive Topline Results from XRX-OXY-101 …
Jan 19, 2023 Safe and Effective Dosing of XORLO™ CALGARY, Alberta, Jan. 19, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: …See details»